HealthEquity (HQY)
(Delayed Data from NSDQ)
$98.82 USD
+1.62 (1.67%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$98.82 USD
+1.62 (1.67%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Zacks News
Is a Surprise Coming for HealthEquity (HQY) This Earnings Season?
by Zacks Equity Research
HealthEquity (HQY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
HealthEquity (HQY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
HealthEquity (HQY) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) delivers strong growth in Service, Custodial and Interchange segments in Q3.
HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) delivered earnings and revenue surprises of 17.14% and 1.90%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: HealthEquity (HQY) Q3 Earnings Expected to Decline
by Zacks Equity Research
HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is HealthEquity (HQY) Down 11.5% Since Last Earnings Report?
by Zacks Equity Research
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HealthEquity (HQY) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q2.
Analysts Estimate HealthEquity (HQY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: HealthEquity, Alarm.com, Stoneridge, Mercer and Bottomline Technologies
by Zacks Equity Research
Zacks.com featured highlights include: HealthEquity, Alarm.com, Stoneridge, Mercer and Bottomline Technologies
These 5 Toxic Stocks Could be Poisoning Your Portfolio
by Zacks Equity Research
Investors who can figure out the overpriced toxic stocks and shun them at the right time are the ones that are likely to benefit.
HealthEquity (HQY) Up 2.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for June 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
HealthEquity (HQY) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q1.
HealthEquity (HQY) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
HealthEquity (HQY) delivered earnings and revenue surprises of -2.27% and -1.29%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions and Medical-Surgical Solutions segments.
TVTY vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TVTY vs. HQY: Which Stock Is the Better Value Option?
Can HealthEquity (HQY) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is HealthEquity (HQY) Up 15.1% Since Last Earnings Report?
by Zacks Equity Research
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain HealthEquity Stock for Now
by Zacks Equity Research
Investor confidence remains high in HealthEquity (HQY) stock, thanks to solid prospects.
HealthEquity (HQY) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
HealthEquity's (HQY) fiscal fourth-quarter earnings benefit from higher revenues and solid performing Service, Custodial and Interchange segments.
HealthEquity (HQY) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
HealthEquity (HQY) delivered earnings and revenue surprises of 14.71% and 1.36%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why HealthEquity (HQY) Might Surprise This Earnings Season
by Zacks Equity Research
HealthEquity (HQY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.